Physician profile
Emily Sizer
NPI 1164170064
$1,823.74
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $601 · 2023: $711 · 2024: $512.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,223.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,223.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $834.62 | 2022-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $215.73 | 2022-2024 | Xifaxan |
| Qol Medical, LLC | $145.90 | 2022-2024 | Sucraid, Sucraid |
| E.R. Squibb & Sons, L.L.C. | $118.48 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $99.70 | 2022-2024 | Entyvio, Gattex |
| Celgene Corporation | $80.88 | 2022-2023 | Zeposia |
| Aimmune Therapeutics, INC. | $59.84 | 2024 | |
| Pfizer INC. | $50.12 | 2022-2024 | |
| Redhill Biopharma INC. | $41.28 | 2022-2023 | Aemcolo, Movantik, Talicia |
| Ironwood Pharmaceuticals, INC | $30.44 | 2022-2023 | Linzess |
| Gilead Sciences, INC. | $27.81 | 2023-2024 | |
| Janssen Biotech, INC. | $23.91 | 2023 | Stelara |
| Genzyme Corporation | $22.00 | 2024 | |
| Alnylam Pharmaceuticals INC. | $17.40 | 2022 | |
| Evoke Pharma, INC. | $17.24 | 2023 | Gimoti |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $13.33 | 2023 | Hadlima |
| Intercept Pharmaceuticals, INC. | $12.62 | 2022 | |
| Nestle Healthcare Nutrition INC. | $12.44 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Sizer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.